Heteroaryl-O-glucosides as novel sodium glucose co-transporter 2 inhibitors. Part 1.

[1]  A. Wakamatsu,et al.  SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. , 2005, Life sciences.

[2]  B. Conway,et al.  Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[3]  M. D'Andrea,et al.  Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1) , 2003, Journal of cellular biochemistry.

[4]  E. Wright,et al.  A glucose sensor hiding in a family of transporters , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Umemura,et al.  Pyrazole-O-glucosides as novel Na(+)-glucose cotransporter (SGLT) inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[6]  K. Tsuda,et al.  Beneficial Effect Of T‐1095, A Selective Inhibitor Of Renal Na+–Glucose Cotransporters, On Metabolic Index And Insulin Secretion In Spontaneously Diabetic Gk Rats , 2002, Clinical and experimental pharmacology & physiology.

[7]  J. Nuss,et al.  Current therapies and emerging targets for the treatment of diabetes. , 2001, Current pharmaceutical design.

[8]  P. Molina,et al.  Synthesis of the indole alkaloids meridianins from the tunicate Aplidium meridianum , 2001 .

[9]  S. Doggrell,et al.  T-1095: Antidiabetic sodium-glucose cotransporter inhibitor , 2001 .

[10]  V. Watts,et al.  Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. , 2000, Journal of medicinal chemistry.

[11]  M. Somei,et al.  Simple syntheses of indol-1-yl glucosides , 2000 .

[12]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[13]  R. Kinne,et al.  Probing the conformation of the sugar transport inhibitor phlorizin by 2D-NMR, molecular dynamics studies, and pharmacophore analysis. , 2000, Journal of medicinal chemistry.

[14]  M. Tsuda,et al.  Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring. , 1999, Journal of medicinal chemistry.

[15]  T. Tanaka,et al.  Na(+)-glucose cotransporter inhibitors as antidiabetic agents. II. Synthesis and structure-activity relationships of 4'-dehydroxyphlorizin derivatives. , 1998, Chemical & pharmaceutical bulletin.

[16]  Y. Kanai,et al.  Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney * , 1995, The Journal of Biological Chemistry.

[17]  M. Hediger,et al.  The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression. , 1994, The Journal of biological chemistry.

[18]  A. Bell,et al.  2(1H)-quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives. , 1989, Journal of medicinal chemistry.

[19]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.